Short dysfunctional telomeres impair tumorigenesis in the INK4a(Δ2/3) cancer-prone mouse

Cell

Volumn 97, Issue 4, 1999, Pages 515-525

  Greenberg, Roger A ^c   Chin, Lynda ^a,b   Femino, Andrea ^c   Kee Ho, Lee ^a   Gottlieb, Geoffrey J ^d   Singer, Robert H ^c   Greider, Carol W ^e   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL AGING; CONTROLLED STUDY; DNA DAMAGE; ENZYME DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TELOMERE; TUMOR SUPPRESSOR GENE;

ANIMALIA; RODENTIA;

EID: 0000146723     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80761-8     Document Type: Article

References (58)

1. Bacchetti, S. (1996). Telomere maintenance in tumor cells. Cancer Surv. 28, 197-226.
2. ARF links the tumor suppressors Rb and p53. Nature 395, 124-125.
3. Bednarek, A.K., Chu, Y., Slaga, T.J., and Aldaz, C.M. (1997). Telomerase and cell proliferation in mouse skin papillomas. Mol. Carcinog. 20, 329-331.
4. Bertrand, E., Chartrand, P., Schaefer, M., Shenoy, S.M., Singer, R.H., and Long, R.M. (1998). Localization of ASH1 mRNA particles in living yeast. Mol. Cell 2, 437-445.
5. Blasco, M.A., Rizen, M., Greider, C.W., and Hanahan, D. (1996). Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12, 200-204.
6. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., and Greider, C.W. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
7. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
8. Broccoli, D., Godley, L.A., Donehower, L.A., Varmus, H.E., and deLange, T. (1996). Telomerase activation in mouse mammary tumors: Lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765-3772.
9. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel, R.R. (1995). Telomere elongation in immortal human cells without detectable telomerase activity. EMBO 14, 4240-4248.
10. Bryan, T.M., Marusic, L., Bacchetti, S., Namba, M., and Reddel, R.R. (1997). The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 6, 921-926.
11. Chadeneau, C., Siegel, P., Harley, C.B., Muller, W.J., and Bacchetti, S. (1995). Telomerase activity in normal and malignant murine tissues. Oncogene 11, 893-898.
12. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.-L, Gottlieb, G.J., Greider, C.W., and Depinho, R.A. (1999). p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, this issue, 527-538.
13. Conzen, S.D., and Cole, C.N. (1995). The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts. Oncogene 11, 2295-2302.
14. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO 11, 1921-1929.
15. Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R.L., Lansdorp, P.M., Sedivy, J.M., and Weinberg, R.A. (1998). Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728.
16. ARF tumor suppressor. Genes Dev. 12, 2434-2442.
17. Dykhuizen, D. (1974). Evolution of cell senescence, atherosclerosis and benign tumors. Nature 251, 616-618.
18. Femino, A.M., Fay, F.S., Fogarty, K., and Singer, R.H. (1998). Visualization of single RNA transcripts in situ. Science 280, 585-590.
19. Greenberg, R.A., Allsopp, R.C., Chin, L., Morin, G.B., and DePinho, R.A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730.
20. Greenberg, R.A., O'Haga, R.C., Deng, H., Xiao, Q., Hann, S.R., Adams, R.R., Lichsteiner, S., Chin, L., Morin, G., and DePinho, R.A. (1999). Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226.
21. Hara, E., Tsurui, H., Shinozaki, A., Nakada, S., and Oda, K. (1991). Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Comm. 179, 528-534.
22. Harley, C.B., Futcher, A.B., and Greider, C.W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
23. Hayflick, L., and Moorehead, P.S. (1961). The serial cultivation of human diploid strains. Exp. Cell. Res. 25, 585-621.
24. ARF. Cell 91, 649-659.
25. Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F., and Sherr, C.J. (1998). Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95, 8292-8297.
26. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and deLange, T. (1999). P53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325.
27. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J.W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
28. Kipling, D., Ackford, H.E., Taylor, T.A., and Cooke, H.J. (1991). Mouse minor satellite genetically maps to the centromere and is physically linked to the proximal telomere. Genomics 11, 235-241.
29. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
30. Kraemer, P.M., Ray, F.A., Brothman, A.R., Bartholdi, M.F., and Cram, L.S. (1986). Spontaneous immortalization rate of cultured Chinese hamster cells. J. Natl. Cancer Inst. 76, 703-709.
31. Lee, H.W., Blasco, M.A., Gottlieb, G.J., Horner, J.W., Greider, C.W., and DePinho, R.A. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574.
32. Lin, A.W., Barradas, M., Stone, J.C., van Aelst, L., Serrano, M., and Lowe, S. (1998). Premature senescence involving p53 and p16 is activated in response to constituitive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008-3019.
33. Lloyd, A.C, Obermuller, F., Staddon, S., Barth, C.F., McMahon, M., and Land, H. (1997). Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11, 663-677.
34. Lundblad, V., and Blackburn, E.H. (1993). An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 73, 347-360.
35. Martin-Rivera, L., Herrera, E., Albar, J.P., and Blasco, M.A. (1998). Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 95, 10471-10476.
36. McEachern, M.J., and Blackburn, E.H. (1996). Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev. 10, 1822-1834.
37. Naito, T., Matsuura, A., and Ishikawa, F. (1998). Circular chromosome formation in a fission yeast mutant defective in two ATM homologues. Nat. Genet. 20, 203-206.
38. Nakamura, T.M., Cooper, J.P., and Cech, T.R. (1998). Two modes of survival of fission yeast without telomerase. Science 282, 493-496.
39. Niida, H., Matsumoto, T., Satoh, H., Shiwa, M., Tokutake, Y., Furuichi, Y., and Shinkai, Y. (1998). Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19, 203-206.
40. ARF links the tumor suppressor p53 to Ras. Nature 395, 125-126.
41. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
42. Prowse, K.R., and Greider, C.W. (1995). Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822.
43. Radfar, A., Unnikrishnan, I., Lee, H.W., DePinho, R.A., and Rosenberg, N. (1998). p19(Arf) induces p-53-dependent apoptosis during abelson virus-medicated pre-B cell transformation. Proc. Natl. Acad. Sci. USA 95, 13194-13199.
44. Rudolph, K.L., Chang, S., Lee, H-W., Blasco, M., Gottlieb, G.J., Greider, C., and DePinho, R.A. (1999). Longevity, stress response, and cancer in aging telomerase deficient mice. Cell. 96, 701-712.
45. Sager, R. (1991). Senescence as a mode of tumor suppression. Environ. Health Perspect. 93, 59-62.
46. Serrano, M., Hannon, G.J., and Beach, D. (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature 366, 704-707.
47. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
48. Shay, J.W., Pereira-Smith, O., and Wright, W.E. (1991). A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33-39.
49. Sherr, C.J. (1998). Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991.
50. Stott, F.J., Bates, S., James, M.C., McConnell, B.B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K.H., and Peters, G. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001-5014.
51. Vaziri, H., and Benchimol, S. (1998). Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282.
52. Wang, J., Xie, L.Y., Allan, S., Beach, D., and Hannon, G.J. (1998). Myc activates telomerase. Genes Dev. 12, 1769-1774.
53. Wright, W.E., and Shay, J.W. (1995). Time, telomeres and tumours: Is cellular senescence more than an anticancer mechanisms? Trends Cell Biol. 5, 293-297.
54. Wu, K.J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., and Dalla-Favera, R. (1999). Direct activation of TERT transcription by c-Myc. Nat. Genet. 21, 220-224.
55. Zhang, Y., Xiong, Y., and Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways. Cell 92, 725-734.
56. Zhu, J., Woods, D., McMahon, M., Bishop, J.M. (1998). Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997-3007.
57. Zijlmans, J.M., Martens, U.M., Poon, S.S., Raap, A.K., Tanke, H.J., Ward, R.K., and Lansdorp, P.M. (1997). Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl. Acad. Sci. USA 94, 7423-7428.
58. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., and Roussel, M.F. (1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433.